UP - logo
E-resources
Full text
Peer reviewed Open access
  • CNOT7 regulates lipid depos...
    Li, Jiahui; Wen, Weiheng; Li, Jitong; Liu, Tiancai; Sun, Jia; Chen, Hong

    Biochemical and biophysical research communications, 08/2024, Volume: 721
    Journal Article

    In recent years, the incidence rate of nonalcoholic fatty liver disease (NAFLD) has ascended with the increasing number of metabolic diseases such as obesity and diabetes, which will bring great medical burden to society. At present, multiple scientific experiments have found that the CCR4-NOT complex can participate in regulating obesity and energy metabolism. This study is designed to explore the role and mechanism of CCR4-NOT transcription complex subunit 7 (CNOT7), a subunit of the CCR4-NOT complex in liver lipid deposition. To establish the NAFLD cell model, palmitic acid (PA) was utilized to stimulate HepG2 cells and LO2 cells, promoting intracellular lipid deposition. CNOT7 was knockdown by siRNA and lentivirus to evaluate the effect of CNOT7 in NAFLD. Our results demonstrated that the expression of CNOT7 was increased in the NAFLD cell model. After knocking down CNOT7, the lipid deposition declined in HepG2 or LO2 cells treated by PA reduced. We found the lipid synthesis genes and the lipid uptake and transport factors in the CNOT7 knockdown group were significantly downregulated compared to the non-knockdown group. Furthermore, knockdown of CNOT7 might promote fatty acid oxidation. Knocking down CNOT7 can improve lipid deposition and CNOT7 may be a potential therapeutic target for NAFLD. •CNOT7 could become a target for improving liver lipid deposition.•After knocking down CNOT7, the lipid synthesis genes were significantly downregulated.•The knock down of CNOT7 also affected lipid uptake and transport factors and fatty acid oxidation genes.•CNOT7 could regular plenty of metabolic genes.